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Frequent occurrence of woodchuck hepatitis virus DNA (WHV DNA) integration into or in proximity to myc oncogenes
and in the win locus of cellular genome in woodchuck hepatocellular carcinomas (HCC) has been described by several
authors. We report a further cellular locus as a recurrent target for WHV integration in woodchuck HCCs. A WHV DNA
integration and its cellular flanking regions were cloned from a HCC developed in a chronically WHV-infected woodchuck.
Sequence analysis showed integration of rearranged C, PreS1, and 5* truncated X regions of the WHV genome, located in
a cellular locus previously described for WHV integration in another woodchuck HCC. The two integration sites are only
about 0.5 kb apart. In addition to Alu-like repeats and a gag-like coding region, previously described, we found several
features of MAR (matrix attachment region) chromosomal sequences in the normal cellular locus, leading us to predict that
part of it might be a previously unrecognized MAR. q 1995 Academic Press, Inc.
Woodchuck hepatitis virus (WHV) and its natural host, 11). In addition, clustering of WHV integrations in a new
the woodchuck (Marmota monax), are studied as a model cellular locus, win, in a group of HCCs characterized by
for hepatitis B virus (HBV)-induced liver cancer in humans N-myc2 activation without a nearby WHV insertion, led
(1). Both viruses are members of the hepadnavirus family to the definition of this locus as another target for WHV
and share many structural, biological, and pathogenic integration in a subset of liver tumors (12). A long-range
properties, such as genome organization, replication cy- N-myc2 activation was also postulated, similar to c-myc
cle, induction of acute and chronic infections, and a close and evi-1 activation by distant retrovirus insertions in
association of chronic infection with hepatocellular carci- rodent hematopoietic malignancies (13, 14).
noma (HCC) development (2, 3). The finding of viral DNA The study of further integrations should lead to the
integration in the chromosomal DNA in most clonally discovery of other preferential targets for viral integration
expanded human and woodchuck liver tumors of hepad- that could identify chromosomal regions in which inser-
navirus carriers has suggested a role of viral integration tional mutagenesis by WHV can contribute to liver cell
in the carcinogenic process. Integration is not an essen- transformation.
tial step in the replication cycle of hepadnaviruses and, This paper reports the analysis of a WHV integration
thus, probably occurs via illegitimate recombination (4, and its cellular flanking regions in a woodchuck HCC
5); integrated sequences are frequently highly re- obtained at autopsy from a naturally WHV-infected fe-
arranged (see 6 for review). male woodchuck (W594), supplied by the International
Extensive studies of HBV insertions in human HCCs Animal Exchange Inc., Michigan. The woodchuck was
have failed to reveal common sites of integration in host kept at the Istituto Superiore di Sanita` animal house for
DNA (7), while a quite different picture has emerged for 24 months. During this period the animal was subjected
WHV integrations in woodchuck HCCs. The cellular ge- to experimental hepatitis delta virus infection and sura-
nomic regions containing members of the myc oncogene min treatment in the framework of antiviral studies. The
family were shown to be targets for WHV integration in animal was constantly plasma WHV DNA positive (4–
over 50% of HCCs, resulting in transcriptional activation 380 ng/ml) by dot-blot hybridization. At autopsy, three
of these oncogenes, mediated by the WHV enhancer (8– distinct tumors (I, II, and III) were clearly visible in the
liver and were 2 to 4 cm in diameter. Tumor masses and
The nucleotide sequence data reported in this paper have been normal liver tissue were resected and stored at 0807.
deposited in the EMBL nucleotide sequence database under Accession Three fragments from tumor I were analyzed in this work.
No. X90998.
The characterization of integrated WHV DNA and the1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (39-6) 44-53-369. cellular flanking regions was performed according to a
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tained the right unknown cellular sequence flanking the
WHV integration; by virtue of size similarity, the 0.5-kb
Bgl II/PstI viral subportion of this fragment was assumed
to correspond to the 0.5-kb Bgl II/PstI region of the WHV
genome, map positions 2534 to 3051 in the WHV se-
quence with Accession No. M18752 (16). Figure 2B
shows, in an enlarged form, the region completely cloned
and sequenced. The strategy applied and the primers
used for the characterization of the right part are reported
in Fig. 2C. Primers 02966–A2603, from the 0.5-kb se-
quence of the WHV genome located between the Bgl II
and PstI sites, were inversely oriented so as to obtain a
polymerization proceeding from A2603 toward the Bgl II
site, and from 02966 toward the PstI site. According to
the IPCR procedure, a ligation step at low DNA concen-
tration (2.5 mg/ml) of PstI-digested tumoral DNA circular-FIG. 1. Southern blotting of total DNA extracted from HCC tissue of
W594. Blotted DNA was hybridized with a 32P-labeled WHV whole ge- ized the 1.5-kb PstI fragment containing the unknown
nome probe. DNA was digested prior to electrophoresis with Bgl II/PstI cellular flanking sequence; this latter became amplifiable
(lane 1), Bgl II (lane 2), and PstI (lane 3). Sizes of hybridizing restriction by PCR with primer pair 02966–A2603, together with the
fragments, in kilobases, are reported on both sides and were estimated
viral/cellular junction. As no products were visible onby means of molecular weight markers run in parallel lanes. Bgl II and
agarose gel after IPCR with 02966–A2603, a secondPstI have a single conserved target site in the WHV genome. It was
assumed that if a viral restriction site is present in the integration, round of amplification was carried out with the nested
digestion with the relative enzyme will produce two fragments both primer pair 03010–A2567. A product of expected size
capable of hybridizing with the WHV probe by virtue of WHV sequences that was absent in parallel negative controls was thus
at either end. On this basis, the resulting hybridization patterns from
obtained. The amplified fragment was digested with Bgl IIsingle digestions were interpreted as follows: one band shows the
and PstI and cloned in BamHI- and PstI-digested pGEM-absence of the corresponding restriction site in the integration; two
bands show the presence of the site. 3Z Vector (Promega) giving origin to pINV39; for sequenc-
ing, two subclones, pH5 and pS10, were also derived as
described in the legend to Fig. 2C. Sequencing was car-
previously described strategy that includes restriction ried out by the Sequenase version 2.0 DNA sequencing
analysis by Southern blotting and hybridization with a kit (USB) or by the Taq Dye Deoxy Terminator Cycle
32P-labeled WHV whole genome probe (gift of J. Sum- Sequencing kit (ABI) according to the manufacturer’s in-
mers) and DNA amplification by inverse and conventional structions. Reactions carried out by the ABI kit were ana-
PCR (15). lyzed in an automatic sequencer A373A (ABI). Double-
The restriction analysis was carried out on DNA ex- strand sequencing was performed.
tracted from HCC tissue of W594. Digestion with KpnI A control for a possible artifactual IPCR amplification
(which does not cut the WHV genome) allowed us to was carried out by testing the primer B3NA1313 (de-
establish that a single integration was present in the signed from the obtained flanking sequence) in conven-
examined fragment, because a single band hybridizing tional PCR with A2567. The template was the same batch
with the WHV probe was produced (data not shown). of tumoral DNA employed in the IPCR. A product of the
Figure 1 shows the results of digestion with Bgl II and predicted size was obtained, thus confirming the IPCR
PstI, which have a single conserved target site in the result.
WHV genome. Two hybridizing fragments of 18 and 4.9 Figure 2D reports the strategy that was followed for the
kb (lane 2) and of 5.5 and 1.5 kb (lane 3) were produced, characterization of the left flanking sequence and of the
respectively, by Bgl II and PstI single digestions (rem- remaining viral integrated sequences by conventional
nants of viral replication are also visible only in lane 3, PCR. This strategy was based on the data obtained from
in the size of 3 kb; a different batch of tumor DNA, with the comparison of the right cellular flanking sequence with
same integration pattern but higher level of replicative the sequences from the GenBank and EMBL databanks,
intermediates, was used in lane 3). Bgl II/PstI double di- performed by means of the FastA program of the GCG
gestion produced three fragments of 4.4, 1.0, and 0.5 kb package. It was found that the obtained cellular sequence
(lane 1). The same bands were observed in DNA ex- showed 100% homology to the region between positions
tracted from a total of three fragments of tumoral tissue, 1184 and 1728 (see Fig. 3) of a 4305-bp-long woodchuck
indicating a clonality of the tumor with regard to the chromosomal sequence, B3N, described below in the text
integration (data not shown). (17). Two cellular primers, B3NS735 and B3NS1010, were
The restriction map deduced from the results of Fig. identified on the B3N sequence about 0.45 and 0.15 kb,
respectively, upstream of nucleotide 1184, and were de-1 is reported in Fig. 2A. The 1.5-kb PstI fragment con-
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FIG. 2. (A) Bgl II/PstI restriction map of the region of WHV DNA integration in liver tumor DNA from woodchuck W594. Position of restriction sites
(P, PstI; B, Bgl II) and size of the fragments, in kilobases (kb), are reported. Cellular and viral sequences are depicted as indicated in the box at the
bottom to the right. (B) Enlarged form of the region completely cloned and sequenced. The fragment used as the template for IPCR is indicated.
(C and D) PCR products and cloned fragments important for characterization of the right (C) and the left (D) parts of the integration. Amplified
fragments, PCR primers, and vector sequences are depicted as indicated in the box. Each amplified or cloned fragment is positioned under the
correspondent region of the enlarged map. Vector sequences are reported at the two ends of those fragments that were cloned. The name of each
primer is reported above each arrow, while their sequences are as follows: B3NS735, 5* TTTGTCTGATTGGGTACCCGCTTGTGTTCA 3*; B3NS1010,
5* CTTCAGCCAAATAAAGGCTGTATGAGTTGTCTACC 3*; B3NA1313, 5* TGGGAAATCGAGCAAACAGTACTTCAAGCACAG 3*; 02490, 5* CTTCTA-
GGTCCCCCAGAAGACGCACTCCC 3*; 02966, 5* GGAACACAGACAGCTAGTGCAACATA-ATGGGC 3*; 03010, 5* GTCACCTTCAATCCAGACAAAATA-
GCAGCATGGT 3*; A1923, 5* GAAGTCGCATGCATTTATGCCTACAGCCTCC 3*; A2567, 5* ATTGAGAGCGTCTGCGAC-GCGGTGATTGAGA 3*; A2603,
5* ATGTACCCATTGAAGATCAGCAGTTGGCAGATG 3*. Conditions of IPCR and PCR were previously reported in detail (15). Both first and nested
inverse PCR products are represented as two separate fragments joined head-to-tail by a dotted line. The name of each plasmid is reported to the
left. pINV39 contains the Bgl II/PstI fragment obtained from the nested IPCR product; pH5 and pS10 were derived from pINV39 by excision of a
HindIII or SacI fragment, respectively. The Bgl II sites marked by an asterisk were present in the fragment prior to cloning but they are absent in
the recombinant plasmids because of ligation with the compatible BamHI end of the vector. pTGRi2 and pTGRi4 contain, in the opposite orientation,
the same PCR product, amplified with primer pair B3NS735-02490; pD2P and pD2N were derived from pTGRi2 by excision of a PstI or NcoI
fragment, respectively; pD4P was derived from pTGRi4 by excision of a PstI fragment. Relevant restriction sites (B, Bgl II; P, PstI; S, SacI; H, HindIII;
N, NcoI) are reported.
signed to be oriented 5*–3* toward the viral integrated template. Amplified fragments were obtained whose dif-
ference in size was consistent with the distance betweensequences. Each primer was used in PCR together with
viral primer 02490, using W594 liver tumor DNA as the the cellular primers on the B3N sequence. These data,
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FIG. 3. (A) Schematic representation of results from a sequence comparison between B3N (sequence of unoccupied b3n cellular locus, Accession
No. m60765) and W594B3N (sequence of the region containing integrated WHV-DNA in the W594 liver tumor). Cellular sequences are reported as
a thin line, viral sequences as a thick one. The vertical black arrow above B3N shows the site of WHV DNA integration previously described in
another woodchuck liver tumor (17). Correspondent regions of B3N and W594B3N are delimited by dashed lines; numbers at the ends of such
regions indicate nucleotide positions in the respective sequences. (B) Regions of the W594B3N sequence containing the left and the right viral/
cellular junctions, compared with homologous parts of the B3N and WHV sequences (WHV sequence with Accession No. m18752). Two arrows
indicate a repeated sequence stretch. Dotted boxes show regions homologous to both the B3N and WHV sequences. Positions of relevant nucleotides
on these two latter sequences are indicated. (C) Regions of WHV genome integrated in the W594 liver tumor. Viral open reading frames (P,
polymerase; C, core; S1, preS1; S2, preS2; S, WHsAg; X, X gene) are reported above a line representing the linearized 3323-bp WHV genome.
Integrated regions, reported as thick lines and positioned under the viral genome, are joined by dotted lines to show how they are linked in the
integration. Nucleotide position in reference WHV sequence is shown at the ends of each fragment. Inserted nonviral dinucleotides are also reported.
confirmed by sequencing, showed that the cellular se- integration occurred in a woodchuck HCC (17). The se-
quence had been obtained from a 4.3-kb EcoRI fragmentquence used for designing B3NS735 and B3NS1010 was
effectively linked to the left end of the integrated viral DNA. cloned from normal liver tissue. Since the clone was
named B3N, further in the text we shall refer to the cellu-The PCR product obtained with primer pair B3NS735–
02490 was cloned in the pGEM-T Vector (Promega), re- lar sequence as the ‘‘B3N sequence’’ and to the cellular
locus as the ‘‘b3n locus.’’sulting in pTGRi2 and pTGRi4, which have the same insert
in the opposite orientation. The sequence of the integra- The complete sequence of the present study was
termed W594B3N. Figure 3A schematically shows thattion was completed by means of plasmids pTGRi2 and
pTGRi4, and their derivatives pD2P, pD2N, and pD4P positions 1 to 391 and 1942 to 2486 of the W594B3N
sequence coincide with positions 735 to 1125 and 1184and by direct sequencing of the PCR product amplified
with primer pair B3NS1010–A1923. to 1728, respectively, of B3N. Some point mutations were
observed in region 200–391 of the W594B3N in compari-The analysis of both cellular flanking sequences con-
firmed that the viral DNA is completely inserted in a son with the correspondent region of B3N. The integra-
tion site in the W594 liver tumor is located only aboutwoodchuck cellular sequence previously described: it is
the normal chromosomal counterpart in which a WHV 0.5 kb from the previously described site.
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In Fig. 3B, the sequences close to the left and right sizes the importance of the common cellular site of inte-
gration rather than the viral integration pattern.junctions are reported. Comparison with the B3N and
WHV sequences was carried out. The site of recombina- Several considerations can be made which concern a
possible role in tumorigenesis of the genetic elementstion in the left junction can be considered to be nucleo-
tide A, present both at position 1128 of B3N and at posi- (Alu-like repetitive sequences and a gag-like coding re-
gion) identified in the locus by Yamazoe et al. (17). Com-tion 2881 of WHV. The sequences reported in the dotted
box show that local limited homology exists between parison with the sequences from databanks revealed
that most Alu-like sequences present in B3N are highlythe B3N and WHV sequences, perhaps involved in the
recombination mechanism. homologous to the identifier (ID) type (19) of rat repetitive
sequence (data not shown). Reports of overexpressionA more complex structure is present in the right junc-
tion. The viral end is linked to region 1119–1144 of B3N, of repetitive sequences in rat tumors (20) and of ID se-
quences in transformed cell lines (21), as well as a possi-which is inverted in comparison to the orientation in B3N.
The CA dinucleotide shared both by B3N (positions ble involvement of ID in cell differentiation (22), seem to
indicate a possible role for overexpression of ID repeated1144–1143, complementary strand) and by WHV (posi-
tions 2163–2162, complementary strand) can be consid- sequences in tumorigenesis. Yet, a mechanism involving
transcriptional activation of the ID repeats present in b3nered to be the site of recombination. A short region of
homology between the B3N and WHV sequences, re- by WHV integration is not consistent with the noted recur-
rence of integration in this locus: since a multitude ofported in the dotted box, is also present in this junction.
The inverted region 1119–1144 of B3N is linked to a Alu-like sequences are interspersed in the genome, this
hypothetical mechanism should have no need for site-direct repeat of region 1184–1195 of the same sequence,
as indicated by the two arrows positioned under the specific integration. As for the gag-like coding region, it
is not known if it is expressed in the liver; even thoughsequence W594B3N in Fig. 3B.
Figure 3C schematically reports the structure of the it was expressed and its expression was affected by viral
integration, no definitive evidence of involvement of gagintegrated WHV DNA, composed of three separate por-
tions of viral genome. Proceeding 5*–3* along the proteins in cell transformation has been reported to date.
The careful examination of the B3N sequence, carriedW594B3N sequence and left to right along its schematic
representation in Fig. 3A, fragment 2881–2934 of the out in search of other possible unrecognized features
that might indicate a putative function(s) of b3n (possiblyWHV genome is linked, by an inserted nonviral TA dinu-
cleotide, to the fragment 1646–1944; an inserted AC di- affected by WHV insertion), has pointed out that the re-
gion 2556–2965, located to the right with respect to thenucleotide links this latter fragment to the inverted frag-
ment 2162–3316 of the WHV genome. The P, C, PreS1, two sites of WHV insertion, has a high AT content (70%).
This finding is characteristic of a group of sequencesand truncated X genes are present in a rearranged man-
ner with respect to the viral genome. On the whole, this termed MAR (matrix attachment region) or SAR (scaffold
attachment region). These sequences are found exclu-viral integration is somewhat different from that pre-
viously described. sively in noncoding regions and, although they lack a
consensus sequence, they share recognizable motifsRecurrent viral integration into a common region of
chromosomal DNA in independent tumors is generally (23–25). Computer analysis revealed that the region
2556–2965 of B3N contains high density of MAR motifs;considered evidence of a causal link between this event
and tumor development, even though it is only a single the region also lacks overlapping coding regions (17).
These features indicate that this part of b3n might be astep of the complex process ultimately leading to tumoral
transformation. The clonality of a recurrent viral integra- MAR. In the cell, MAR chromosomal sequences carry
out several functions, both structural and regulative.tion in a tumor is assumed to be evidence that integration
is an early event and, possibly, that a selection process MARs are involved in the organization of interphase chro-
matin and mitotic chromosomes into functional ‘‘loops’’has driven the clonal expansion of a cell with the ‘‘appro-
priate’’ integration among several cells containing ‘‘inap- or ‘‘domains’’ (26) by physical attachment to a protein
framework, termed ‘‘scaffold’’ at mitosis (27, 28) or ‘‘nu-propriate’’ integrations. Several examples of common
sites for viral integrations were described for the first clear matrix’’ at interphase (29). Involvement in the regula-
tion of gene expression (30–32), also in a tissue-specifictime in malignancies related to slow-transforming retrovi-
ruses (see 18 for review). fashion (33), as well as in initiation of DNA replication
(34, 35), was also reported. It can be speculated thatThe occurrence of WHV integration in the b3n locus
in two different woodchuck HCCs strongly suggests that, deregulation or disruption of normal functions of the b3n
MAR by WHV integration might indirectly affect the ex-in addition to the myc and win loci (8–12), b3n is a
further target for WHV integration in HCC and implies that pression of some cellular gene(s), critical for cell growth
and regulation, possibly located in the functional chroma-integration in this locus may play a role in the induction of
a subset of liver tumors, by an unknown mechanism. The tin loop controlled by the MAR, also at a large distance
from the site of integration. This hypothesis is substanti-different viral pattern in the two tumors further empha-
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